Anti-Microbial Savior BioteQ Co., Ltd. (TPEX:6864)
52.50
+1.00 (1.94%)
Mar 10, 2026, 10:06 AM CST
TPEX:6864 Revenue
In the year 2024, Anti-Microbial Savior BioteQ had annual revenue of 612.00K TWD, down -15.93%. Anti-Microbial Savior BioteQ had revenue of 267.00K in the half year ending December 31, 2024, with 203.41% growth.
Revenue
612.00K
Revenue Growth
-15.93%
P/S Ratio
2,737.81
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.68B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genomics BioSci & Tech. | 607.89M |
| TaiRx | 15.46M |
| Chunghwa Chemical Synthesis & Biotech | 977.79M |
| G&E Herbal Biotechnology | 311.78M |
| GenMont Biotech Incorporation | 391.48M |
| NeoCore Technology | 190.10M |
| Gwo Xi Stem Cell Applied Technology Co. , | 184.91M |
| Abnova (Taiwan) | 351.30M |